Form 4 Tracker
David Scott Moore

Director · 1 filing · Latest: Jun 11, 2026

Corvus Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CRVS
David Scott MooreDirectorJun 11, 2026
Purchase
$11.5321,700$250.2K21,700